Thomas Dahl

5PUBLICATIONS
4CO-AUTHORS
Gene and molecular therapyMolecular medicineMajor global burdens of diseaseToxicology (incl. clinical toxicology)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 12, 2024
Efficacy of the triple-combination SM-1 in a 5-h phase advance transient insomnia model.

Thomas Dahl, Gary Zammit, Maha Ahmad

|Sep 22, 2022
Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies.

Pantea Kiani, Thomas A Dahl, Jacqueline M Iversen

|Dec 15, 2019
Efficacy of SM-1 in a transient insomnia model.

Thomas Dahl, Lan Bo Chen, Gary Zammit

|Dec 04, 2019
Pharmacodynamic and pharmacokinetic profile of SM-1, a triple-drug combination to increase total sleep time.

Thomas Dahl, Lan Bo Chen, Mika Scheinin

Pageof 1